Gallbladder cancer is a malignant tumor with high mortality. Early diagnosis is significance to improve the prognosis of patients. Gallbladder adenoma is recognized as a kind of precancerous disease, for the past few years, contrast-enhanced ultrasound was used in the diagnosis of biliary tumors. This case is about gallbladder papillary adenoma with carcinogenesis. There is rare literature on the contrast-enhanced ultrasound manifestations of this type of disease. We hope that this report can help improve the recognition of contrast-enhanced ultrasound features and improve the accuracy of early diagnosis of gallbladder cancer.
KimST, ParkJO, LeeJ, LeeKT, LeeJK, ChoiSH, et al. A Phase II study of Gemcitabine and Cisplatin in advanced biliary tract cancer. Cancer. 2006;106(6):1339–46.
5.
AndréT, TournigandC, RosmorducO, ProventS, Maindrault-GoebelF, AveninD, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol. 2004;15(9):1339–43.
6.
Albores-SaavedraJ, HensonDE, SobinLH. The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition. Cancer. 1992;70(2):404–10.
7.
KijimaH, WatanabeH, IwafuchiM, IshiharaN. Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathol Jpn. 1989;39(4):235–44.
8.
KozukaS, TsuboneN, YasuiA, HachisukaK. Relation of adenoma to carcinoma of the gallbladder. Cancer. 1982;50(10):2226–34.
9.
Albores-SaavedraJ, Chablé-MonteroF, González-RomoMA, Ramírez JaramilloM, HensonDE. Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma. Hum Pathol. 2012;43(9):1506–13.
KimSW, KimHC, YangDM, RyuJK, WonKY. Gallbladder carcinoma: causes of misdiagnosis at CT. Clin Radiol. 2016;71(1):e96–109.
12.
YooJ, ChoiJY, LeeKT, HeoJS, ParkSB, MoonSH, et al. Prognostic significance of volume-based metabolic parameters by (18)F-FDG PET/CT in gallbladder carcinoma. Nucl Med Mol Imaging. 2012;46(3):201–6.
13.
ZhangCB, PangLF, BoXB, WangYJ, WangJ, WangYQ. The value of 18F-FDG PET/CT in preoperative assessment of gallbladder carcinoma. Chinese Journal of Clinical Medicine. 2017;24(2):210–13.
14.
WangW, FeiY, WangF. Meta-analysis of contrast-enhanced ultrasonography for the detection of gallbladder carcinoma. Med Ultrason. 2016;18(3):281–28.
15.
YuanHX, CaoJY, KongWT, XiaHS, WangX, WangWP. Contrast-enhanced ultrasound in diagnosis of gallbladder adenoma. Hepatobiliary Pancreat Dis Int. 2015;14(2):201–7.
16.
TsujiS, SofuniA, MoriyasuF, ItokawaF, IshiiK, KuriharaT, et al. Contrast-enhanced ultrasonography in the diagnosis of gallbladder disease. Hepatogastroenterology. 2012;59(114):336–40.
17.
ClaudonM, DietrichCF, ChoiBI, CosgroveDO, KudoM, NolsøeCP, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012 A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound in medicine & biology. 2013;39(2):187–210.
18.
Al BensonBIII, Thomas AbramsA, Edgar Ben-Josef, Mark BloomstonP, Jean BothaF, Bryan ClaryM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7(4):350–91.
19.
WiesingerI, BeyerLP, ZausigN, VerlohN, WiggermannP, StroszczynskiC, et al. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesion: First results. Clin Hemorheol Microcirc. 2018;69(1-2):59–67.
20.
SidhuPS, CantisaniV, DietrichCF, GiljaOH, SaftoiuA, BartelsE, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update (Long Version). Ultraschall Med. 2018;39(2):e2–e44.
21.
Negrão De FigueiredoG, Mueller-PeltzerK, SchwarzeV, ZhangL, RübenthalerJ, ClevertDA. Performance of contrast-enhanced ultrasound (CEUS) compared to MRI in the diagnostic of gallbladder diseases. Clin Hemorheol Microcirc. 2019;73(1):85–93.
22.
DietrichCF, NolsøeCP, BarrRG, BerzigottiA, BurnsPN, CantisaniV, et al. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound in Medicine & Biology. 2020;46:2579–604.
